ORTHOPEDIATRICS CORP (KIDS) Stock Fundamental Analysis
USA - NASDAQ:KIDS - US68752L1008 - Common Stock
16.58 USD
+0.17 (+1.04%)
16.58 USD
0 (0%)
We assign a fundamental rating of 3 out of 10 to KIDS. KIDS was compared to 189 industry peers in the Health Care Equipment & Supplies industry. KIDS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, KIDS is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
KIDS had negative earnings in the past year.
In the past year KIDS has reported a negative cash flow from operations.
KIDS had negative earnings in 4 of the past 5 years.
KIDS had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -9.24%, KIDS is in the better half of the industry, outperforming 62.43% of the companies in the same industry.
KIDS has a Return On Equity of -13.06%. This is in the better half of the industry: KIDS outperforms 64.02% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.24% | ||
| ROE | -13.06% | ||
| ROIC | N/A |
ROA(3y)-4.16%
ROA(5y)-5.62%
ROE(3y)-5.3%
ROE(5y)-7.43%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
KIDS's Gross Margin of 71.73% is amongst the best of the industry. KIDS outperforms 82.54% of its industry peers.
KIDS's Gross Margin has been stable in the last couple of years.
KIDS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 71.73% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.71%
2. Health
2.1 Basic Checks
KIDS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for KIDS has been increased compared to 1 year ago.
KIDS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for KIDS is higher compared to a year ago.
2.2 Solvency
KIDS has an Altman-Z score of 1.72. This is a bad value and indicates that KIDS is not financially healthy and even has some risk of bankruptcy.
KIDS has a Altman-Z score (1.72) which is comparable to the rest of the industry.
KIDS has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.
KIDS has a Debt to Equity ratio (0.28) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.28 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.72 |
ROIC/WACCN/A
WACC8.45%
2.3 Liquidity
KIDS has a Current Ratio of 7.40. This indicates that KIDS is financially healthy and has no problem in meeting its short term obligations.
KIDS's Current ratio of 7.40 is amongst the best of the industry. KIDS outperforms 87.30% of its industry peers.
A Quick Ratio of 3.52 indicates that KIDS has no problem at all paying its short term obligations.
With a decent Quick ratio value of 3.52, KIDS is doing good in the industry, outperforming 70.90% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.4 | ||
| Quick Ratio | 3.52 |
3. Growth
3.1 Past
KIDS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -58.54%.
Looking at the last year, KIDS shows a quite strong growth in Revenue. The Revenue has grown by 19.90% in the last year.
Measured over the past years, KIDS shows a very strong growth in Revenue. The Revenue has been growing by 23.04% on average per year.
EPS 1Y (TTM)-58.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-47.06%
Revenue 1Y (TTM)19.9%
Revenue growth 3Y27.84%
Revenue growth 5Y23.04%
Sales Q2Q%12.23%
3.2 Future
The Earnings Per Share is expected to grow by 12.64% on average over the next years. This is quite good.
KIDS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.25% yearly.
EPS Next Y2.38%
EPS Next 2Y11.52%
EPS Next 3Y12.64%
EPS Next 5YN/A
Revenue Next Year15.23%
Revenue Next 2Y13.84%
Revenue Next 3Y13.25%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
KIDS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year KIDS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as KIDS's earnings are expected to grow with 12.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.52%
EPS Next 3Y12.64%
5. Dividend
5.1 Amount
KIDS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
16.58
+0.17 (+1.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners71.17%
Inst Owner Change-1.6%
Ins Owners5.07%
Ins Owner Change0.88%
Market Cap415.66M
Revenue(TTM)227.41M
Net Income(TTM)-45614000
Analysts83.08
Price Target26.81 (61.7%)
Short Float %6.4%
Short Ratio6.29
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-43.35%
Min EPS beat(2)-89.58%
Max EPS beat(2)2.89%
EPS beat(4)1
Avg EPS beat(4)-50.67%
Min EPS beat(4)-115.9%
Max EPS beat(4)2.89%
EPS beat(8)3
Avg EPS beat(8)-27.23%
EPS beat(12)6
Avg EPS beat(12)-15.09%
EPS beat(16)9
Avg EPS beat(16)3.25%
Revenue beat(2)0
Avg Revenue beat(2)-3.13%
Min Revenue beat(2)-3.78%
Max Revenue beat(2)-2.47%
Revenue beat(4)1
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-3.78%
Max Revenue beat(4)1.19%
Revenue beat(8)2
Avg Revenue beat(8)-0.61%
Revenue beat(12)3
Avg Revenue beat(12)-0.82%
Revenue beat(16)4
Avg Revenue beat(16)-1.04%
PT rev (1m)-22.36%
PT rev (3m)-27.84%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.36%
EPS NY rev (1m)2.65%
EPS NY rev (3m)1.69%
Revenue NQ rev (1m)-1.86%
Revenue NQ rev (3m)-2.37%
Revenue NY rev (1m)-1.65%
Revenue NY rev (3m)-1.6%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.83 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.19 | ||
| P/tB | 2.5 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.95
EYN/A
EPS(NY)-1.23
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.77
OCFYN/A
SpS9.07
BVpS13.93
TBVpS6.64
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.24% | ||
| ROE | -13.06% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 71.73% | ||
| FCFM | N/A |
ROA(3y)-4.16%
ROA(5y)-5.62%
ROE(3y)-5.3%
ROE(5y)-7.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.71%
F-Score3
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.28 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 74.39% | ||
| Cap/Sales | 6.41% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 7.4 | ||
| Quick Ratio | 3.52 | ||
| Altman-Z | 1.72 |
F-Score3
WACC8.45%
ROIC/WACCN/A
Cap/Depr(3y)87.97%
Cap/Depr(5y)110.98%
Cap/Sales(3y)9.42%
Cap/Sales(5y)12.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-58.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-47.06%
EPS Next Y2.38%
EPS Next 2Y11.52%
EPS Next 3Y12.64%
EPS Next 5YN/A
Revenue 1Y (TTM)19.9%
Revenue growth 3Y27.84%
Revenue growth 5Y23.04%
Sales Q2Q%12.23%
Revenue Next Year15.23%
Revenue Next 2Y13.84%
Revenue Next 3Y13.25%
Revenue Next 5YN/A
EBIT growth 1Y-10.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year156.56%
EBIT Next 3Y50.18%
EBIT Next 5YN/A
FCF growth 1Y86.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.73%
OCF growth 3YN/A
OCF growth 5YN/A
ORTHOPEDIATRICS CORP / KIDS FAQ
What is the fundamental rating for KIDS stock?
ChartMill assigns a fundamental rating of 3 / 10 to KIDS.
What is the valuation status of ORTHOPEDIATRICS CORP (KIDS) stock?
ChartMill assigns a valuation rating of 0 / 10 to ORTHOPEDIATRICS CORP (KIDS). This can be considered as Overvalued.
What is the profitability of KIDS stock?
ORTHOPEDIATRICS CORP (KIDS) has a profitability rating of 2 / 10.
What is the financial health of ORTHOPEDIATRICS CORP (KIDS) stock?
The financial health rating of ORTHOPEDIATRICS CORP (KIDS) is 4 / 10.
How sustainable is the dividend of ORTHOPEDIATRICS CORP (KIDS) stock?
The dividend rating of ORTHOPEDIATRICS CORP (KIDS) is 0 / 10 and the dividend payout ratio is 0%.